Gino Pelgrims
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 2
- Gallbladder and Bile Duct Disorders 1
- Advanced Breast Cancer Therapies 1
- Oncology 2
- HER2/EGFR in Cancer Research 1
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Sarah Declerck (1 shared paper)Peter B. Vermeulen (1 shared paper)E. Totté (1 shared paper)R. Van Hee (1 shared paper)Luc Yves Dirix (1 shared paper)Frans B S Oei (1 shared paper)Nanno H. Mulder (1 shared paper)Allan T. van Oosterom (1 shared paper)
- Journals
- Urologic Oncology Seminars and Original Investigations (1 paper)International Journal of Gynecological Cancer (1 paper)Cancer (1 paper)The Lancet Oncology (1 paper)Surgical Endoscopy (1 paper)
- Partner nations
- BelgiumUnited Kingdom
In The Last Decade
Gino Pelgrims
7 papers receiving 503 citations
Gino Pelgrims's Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 331
- Cancer Research 142
- Pulmonary and Respiratory Medicine 160
- Radiology, Nuclear Medicine and Imaging 102
- Genetics 36
Countries citing papers authored by Gino Pelgrims
This map shows the geographic impact of Gino Pelgrims's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gino Pelgrims with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gino Pelgrims more than expected).
Fields of papers citing papers by Gino Pelgrims
This network shows the impact of papers produced by Gino Pelgrims. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gino Pelgrims. The network helps show where Gino Pelgrims may publish in the future.
Co-authors
The 10 scholars most cited alongside Gino Pelgrims, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | 2007 | 16 | |
| 3 | 2016 | 11 | |
| 4 | 2002 | 9 | |
| 5 | 2017 | 9 | |
| 6 | 2022 | 6 | |
| 7 | 1995 | 3 |
About Gino Pelgrims
Gino Pelgrims is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Emergency Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 7 papers that have together received 515 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (2 papers), HER2/EGFR in Cancer Research (1 paper), Breast Cancer Treatment Studies (1 paper), Appendicitis Diagnosis and Management (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Gallbladder and Bile Duct Disorders (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Oncology (331 citations), Cancer Research (142 citations), Pulmonary and Respiratory Medicine (160 citations), Radiology, Nuclear Medicine and Imaging (102 citations) and Genetics (36 citations). Gino Pelgrims has collaborated with scholars based in Belgium and United Kingdom. Frequent co-authors include Sarah Declerck, Peter B. Vermeulen, E. Totté, R. Van Hee, Luc Yves Dirix, Frans B S Oei, Nanno H. Mulder, Allan T. van Oosterom, Bart Wollaert and Eric E. O. Gheuens. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, International Journal of Gynecological Cancer, Cancer, The Lancet Oncology and Surgical Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.